February 26, 2021 by MICHELLE DONOVAN
February 19, 2021
February 16, 2021
A McMaster stem cell research team has made an important early step in developing a new class of therapeutics for patients with a deadly blood cancer.
November 18, 2020
Researchers at McMaster University are studying the saliva-based testing procedures that would enable routine testing of asymptomatic individuals on a large scale.
November 9, 2020
A team of McMaster researchers has been awarded $1.5M from the federal government to further investigate COVID-19.
November 9, 2020
October 7, 2020
Ontario’s Minister of Colleges and Universities Ross Romano has announced that the province is investing $1 million to create a nationally accessible library of compounds that will accelerate the work of McMaster’s Global Nexus for Pandemics and Biological Threats.
September 1, 2020
McMaster is launching The Global Nexus for Pandemics and Biological Threats, to ensure Canada and the world are better able to manage the human and economic devastation of COVID-19 and avert future pandemics.
July 17, 2020
June 25, 2020
McMaster University has garnered $20 million in new funding for 17 COVID-19 research projects from the Canadian Institutes of Health Research (CIHR) and their funding partners.
June 11, 2020
Researchers of the Faculty of Health Sciences who quickly turned their focus to the need for immediate research on the pandemic, have collected almost $9 million of support for 33 COVID-19 studies.
May 26, 2020
McMaster University professor Eric Brown has been awarded a Killam Research Fellowship.
May 14, 2020
Research led by McMaster University's Caressa Tsai and Brian Coombes has resulted in the discovery of a combination punch to treat drug-resistant infections that is showing promise based on testing in mice.
April 14, 2020
McMaster University researchers are racing to create a home-based COVID-19 testing kit, which could potentially be ready to move forward for approvals and manufacturing within months. The COVID-19 self-diagnosis kit would be configured to detect the genetic material of the virus but would work in a manner similar to a home pregnancy test, generating a result on a test strip within 20 minutes.
April 7, 2020
Infectious disease researcher Yingfu Li and his research team raised money and bought N95 masks and goggles for Chinese hospitals during the rise of the COVID-19. More than 20 scientists in China who previously worked with Li or his team members have raised money to buy the same kind of protective gear for Hamilton health-care workers.
March 31, 2020
Congratulations to Dr. Caitlin Mullarkey who has been awarded the 2019-2020 MSU Teaching Award for the Faculty of Health Sciences!
March 20, 2020
Two senior researchers of McMaster University’s Faculty of Health Sciences have received a combined $1.8 million in funding to support new research projects to help combat COVID-19.
February 28, 2020
McMaster University researchers have developed a tool to share with the international health sciences community which can help determine how the virus that causes COVID-19 is spreading and whether it is evolving. Simply put, the tool is a set of molecular ‘fishing hooks’ to isolate the virus, SARS-CoV-2, from biological samples.
February 26, 2020
McMaster University researchers have identified an antibacterial compound made by cannabis plants that may serve as a lead for new drug development.
February 14, 2020
A new group of antibiotics with a unique approach to attacking bacteria has been discovered, making it a promising clinical candidate in the fight against antimicrobial resistance.
January 27, 2020 by McMaster Daily News
November 25, 2019
Research led by scientists from McMaster University has yielded a potent antimicrobial that works against the toughest infectious disease strains. The find could be the beginning of developing new therapeutics to combat drug-resistant infections. The discovery is important as it is directly related to the development of Staphylococcus aureus diseases, known popularly as staph infections, which are the leading cause of the growing global danger of antimicrobial resistance, particularly the Methicillin-resistant (MRSA) strains which are becoming resistant to all current antibiotics.